New scan could reveal brain tumor aggression without surgery

NCT ID NCT00850278

Completed Diagnosis Sponsor: University Hospital, Caen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special PET scan tracer called FLT in 50 adults with brain tumors (gliomas or metastases). The goal was to see if FLT-PET can measure how fast tumor cells are growing, which could help doctors diagnose and predict tumor behavior better than current scans like MRI or MET-PET. Participants received FLT-PET, MET-PET, and MRI before surgery, and results were compared with lab tests and survival data.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FLT (a radioactive tracer for PET imaging)
What this could lead to: If successful, FLT-PET could become a better way to see how aggressive a brain tumor is without surgery, helping doctors plan treatment more accurately.
What could go wrong: This is a small, early imaging study (50 people) that only looks at whether the scan works, not whether it improves outcomes. The tracer may not be better than existing methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm cancer glioma malignant glioma metastatic malignant neoplasm in the brain neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN TUMORS CANCER

Contacts and locations

Locations

Caen University Hospital

Caen, 14033, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.